Class information for:
Level 1: CARBETIMER//POLYERGA//SPLEEN PEPTIDES

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
25399 283 28.9 37%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
0 4 BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY 4064930
210 3       IMMUNOLOGY//JOURNAL OF INTERFERON RESEARCH//NK CELLS 51916
3041 2             PSK//OK 432//IMEXON 2463
25399 1                   CARBETIMER//POLYERGA//SPLEEN PEPTIDES 283

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 CARBETIMER authKW 215797 1% 100% 2
2 POLYERGA authKW 215797 1% 100% 2
3 SPLEEN PEPTIDES authKW 215797 1% 100% 2
4 AMINOGLYCOCONJUGATES authKW 107898 0% 100% 1
5 CARBOXYIMAMIDATE authKW 107898 0% 100% 1
6 CONJUGATES OF AMINO ACIDS AND CARBOHYDRATES authKW 107898 0% 100% 1
7 DIFFERENTIAL CYTOKINE EXPRESSION authKW 107898 0% 100% 1
8 DNCB SKIN TEST authKW 107898 0% 100% 1
9 DUKES C COLORECTAL CARCINOMA authKW 107898 0% 100% 1
10 FACTOR AF2R authKW 107898 0% 100% 1

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Oncology 2791 51% 0% 145
2 Immunology 423 20% 0% 56
3 Medicine, General & Internal 85 10% 0% 27
4 Pharmacology & Pharmacy 83 12% 0% 35
5 CYTOLOGY & HISTOLOGY 54 1% 0% 2
6 Medicine, Research & Experimental 35 5% 0% 15
7 Surgery 30 8% 0% 22
8 Pathology 16 3% 0% 8
9 Hematology 5 2% 0% 6
10 Nursing 5 1% 0% 3

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 HEMATOL ONKOL ODJEL 107898 0% 100% 1
2 IMMUNE TUMOR DIAG 107898 0% 100% 1
3 VET SCI ANIM SCI 21578 0% 20% 1
4 RE KAVETSKY EXPT PATHOL ONCOL RADIOBIOL 20432 2% 3% 6
5 LIM 56 6742 0% 6% 1
6 TOKYO WOMENS MED 3719 0% 3% 1
7 PHARMACEUT SCI PHARMACEUT 3479 0% 3% 1
8 MED BIOMETR INFORMAT 3081 0% 3% 1
9 NUCL MED ONCOL 2200 0% 2% 1
10 CLIN PHARM THER EUT 2073 0% 2% 1

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 EXPERIMENTAL ONCOLOGY 14428 3% 1% 9
2 EKSPERIMENTALNAYA ONKOLOGIYA 7053 3% 1% 9
3 INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY 5314 4% 0% 10
4 CANCER IMMUNOLOGY IMMUNOTHERAPY 2994 4% 0% 11
5 JOURNAL OF IMMUNOPHARMACOLOGY 2133 1% 1% 2
6 VOPROSY ONKOLOGII 1728 2% 0% 5
7 IMMUNOPHARMACOLOGY 1292 1% 0% 4
8 TUMORDIAGNOSTIK & THERAPIE 1244 1% 0% 3
9 CANCER TREATMENT REPORTS 1216 2% 0% 5
10 ACTA PATHOLOGICA MICROBIOLOGICA ET IMMUNOLOGICA SCANDINAVICA SECTION A-PATHOLOGY 1156 1% 1% 2

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 CARBETIMER 215797 1% 100% 2 Search CARBETIMER Search CARBETIMER
2 POLYERGA 215797 1% 100% 2 Search POLYERGA Search POLYERGA
3 SPLEEN PEPTIDES 215797 1% 100% 2 Search SPLEEN+PEPTIDES Search SPLEEN+PEPTIDES
4 AMINOGLYCOCONJUGATES 107898 0% 100% 1 Search AMINOGLYCOCONJUGATES Search AMINOGLYCOCONJUGATES
5 CARBOXYIMAMIDATE 107898 0% 100% 1 Search CARBOXYIMAMIDATE Search CARBOXYIMAMIDATE
6 CONJUGATES OF AMINO ACIDS AND CARBOHYDRATES 107898 0% 100% 1 Search CONJUGATES+OF+AMINO+ACIDS+AND+CARBOHYDRATES Search CONJUGATES+OF+AMINO+ACIDS+AND+CARBOHYDRATES
7 DIFFERENTIAL CYTOKINE EXPRESSION 107898 0% 100% 1 Search DIFFERENTIAL+CYTOKINE+EXPRESSION Search DIFFERENTIAL+CYTOKINE+EXPRESSION
8 DNCB SKIN TEST 107898 0% 100% 1 Search DNCB+SKIN+TEST Search DNCB+SKIN+TEST
9 DUKES C COLORECTAL CARCINOMA 107898 0% 100% 1 Search DUKES+C+COLORECTAL+CARCINOMA Search DUKES+C+COLORECTAL+CARCINOMA
10 FACTOR AF2R 107898 0% 100% 1 Search FACTOR+AF2R Search FACTOR+AF2R

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref.
in cl.		 Shr. of ref. in
cl.		 Citations
1 DEBRABANDER, M , DECREE, J , VANDEBROEK, J , VERHAEGEN, H , JANSSEN, PAJ , (1992) LEVAMISOLE IN THE TREATMENT OF CANCER - ANYTHING NEW.ANTICANCER RESEARCH. VOL. 12. ISSUE 1. P. 177-187 34 55% 12
2 GREENSPAN, EM , ERLICH, R , (1991) LEVAMISOLE AND THE NEW ERA OF CHEMOIMMUNOTHERAPY.CANCER INVESTIGATION. VOL. 9. ISSUE 1. P. 111-124 20 65% 8
3 WIEBKE, EA , GRIESHOP, NA , LOEHRER, PJ , ECKERT, GJ , SIDNER, RA , (2003) ANTITUMOR EFFECTS OF 5-FLUOROURACIL ON HUMAN COLON CANCER CELL LINES: ANTAGONISM BY LEVAMISOLE.JOURNAL OF SURGICAL RESEARCH. VOL. 111. ISSUE 1. P. 63-69 16 46% 8
4 BEREZHNAYA, NM , KOVALCHUK, EV , DENISEVICH, TV , OSIPOVA, EV , KONOVALENKO, VF , TOLSTOPYATOV, BA , TREMBACH, AM , PROTSIK, VS , VOROBJOVA, LI , PINCHOUK, VG , ET AL (1996) THE GROWTH PECULIARITIES OF HUMAN AND MOUSE TUMOUR EXPLANTS AND ISOLATED TUMOUR CELLS UNDER THE INFLUENCE OF IMMUNOMODULATORS DIFFERENT NATURE.EXPERIMENTAL ONCOLOGY. VOL. 18. ISSUE 3. P. 244-250 10 77% 0
5 ARDALAN, B , HUSSEIN, AM , SHANAHAN, WR , SHIELDS, MJ , (1991) CARBETIMER - A REEVALUATION OF A DRUG WITH A NOVEL MECHANISM OF ACTION.CANCER TREATMENT REVIEWS. VOL. 18. ISSUE 1. P. 73-83 9 90% 1
6 STEVENSON, HC , GREEN, I , HAMILTON, JM , CALABRO, BA , PARKINSON, DR , (1991) LEVAMISOLE - KNOWN EFFECTS ON THE IMMUNE-SYSTEM, CLINICAL-RESULTS, AND FUTURE APPLICATIONS TO THE TREATMENT OF CANCER.JOURNAL OF CLINICAL ONCOLOGY. VOL. 9. ISSUE 11. P. 2052-2066 18 35% 89
7 TEMPERO, MA , HAGA, Y , SIVINSKI, C , BIRT, D , KLASSEN, L , THIELE, G , (1995) IMMUNOLOGICAL EFFECTS OF LEVAMISOLE IN MICE AND HUMANS - EVIDENCE FOR AUGMENTED ANTIBODY-RESPONSE WITHOUT MODULATION OF CELLULAR CYTOTOXICITY.JOURNAL OF IMMUNOTHERAPY. VOL. 17. ISSUE 1. P. 47-57 12 46% 19
8 BORGHARDT, J , ROSIEN, B , GORTELMEYER, R , LINDEMANN, S , HARTLEB, M , KLINGMULLER, M , (2000) EFFECTS OF A SPLEEN PEPTIDE PREPARATION AS SUPPORTIVE THERAPY IN INOPERABLE HEAD AND NECK CANCER PATIENTS.ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH. VOL. 50. ISSUE 2. P. 178 -184 7 54% 3
9 HOLCOMBE, RF , MCLAREN, CE , MILOVANOVIC, T , (2006) IMMUNOMODULATION WITH LOW DOSE LEVAMISOLE IN PATIENTS WITH COLONIC POLYPS.CANCER DETECTION AND PREVENTION. VOL. 30. ISSUE 1. P. 94-98 6 46% 10
10 GREM, JL , (1990) LEVAMISOLE AS A THERAPEUTIC AGENT FOR COLORECTAL-CARCINOMA.CANCER CELLS-A MONTHLY REVIEW. VOL. 2. ISSUE 5. P. 131-137 11 41% 18

Classes with closest relation at Level 1


Rank Class id link
1 28487 ADJUVANT SPECIFIC IMMUNOTHERAPY//CHEMOTACTIC INHIBITORS//CHIMERIC ANTIBODY 311
2 21380 LEVAMISOLE//AMINOREX//4 METHYLAMINOREX
3 24295 METHISOPRINOL//INOSINE PRANOBEX//ISOPRINOZINE
4 33598 IMEXON//CYANOAZIRIDINE//AZIRIDINE 2 CARBOXAMIDE
5 21679 POSTOPERATIVE SEPTIC COMPLICATIONS//TREATMENT RELATED TOXICITIES//BOVINE BETALACTOGLOBULIN
6 34944 DENT ORAL SURG 2 HIGASHI KU//P 53 ASSAY//THYMOCYTES DIFFERENTIATION
7 33216 BIMOLANE//PROBIMANE//MST 16
8 26796 1 3 DITHIOLIUM SALTS//DITHIOLIUM SALTS//MESOIONIC PHENOLATES
9 27897 COOPERAT MED//ISOFATTY ACID//PORCINE BCL G
10 17426 IRX 2//IMMUNE SUPPRESSOR CELLS//SERV 151Z2

Go to start page